Drug Trial Radar · NCT05634473
A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
Last checked: Nov 20, 2026Latest source record: Dec 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
280
Planned (sponsor's estimate)
Start
Dec 2022
Primary completion
Feb 2023
Study completion Jun 2023
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 2, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A multicenter, open-label study to evaluate the sensitivity and specificity of inhaled methacholine in bronchial provocation test
Conditions
- Asthma
Interventions
Methacholine ChlorideDrug
Cholinergic agonists
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity analysisTime frame: On the 1 day of administration
- Specificity AnalysisTime frame: On the 1 day of administration
- Provocative dose causing a 20% fall (PD20)Time frame: On the 1 day of administration
- Adverse eventsTime frame: Base line to 3 days after dosing
- heart rate (Vital signs)Time frame: Base line to 3 days after dosing
- oxyhemoglobin saturation (Vital signs)Time frame: Base line to 3 days after dosing
- Recovery of forced expiratory volume in 1 second (FEV 1)Time frame: Base line to 3 days after dosing
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Guangdong Province Hospital of chinese medicine
Guangzhou, Guangdong, China
Liuzhou people's Hospital
Liuzhou, Guangxi, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
The Affiliated Hospital of Inner Mongolia Medical Univercity
Hohhot, Inner Mongolia, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Benxi Central Hospital
Benxi, Liaoning, China
Weifang NO.2 People's Hospital
Weifang, Shandong, China
West China Hospital,Sichuan University
Chengdu, Sichuan, China
Zhejiang Provincial Hospital of Chinese Medicine
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.